Jason Jankowski, MD
Specialty: Urology-Urologic Oncology
- Assistant Professor, CWRU School of Medicine
- Director, Robotic Surgery, UH St John Medical Center
UH St John Medical Center
29101 Health Campus Dr
Westlake, OH 44145
Jason Jankowski, MD is a board-certified, fellowship-trained urologist at University Hospitals and an assistant professor of urology at Case Western Reserve University School of Medicine. His clinical interests include the surgical management of patients with bladder, kidney and prostate cancer with a particular interest in minimally invasive techniques. Dr. Jankowski also sees and treats patients with general urologic conditions like stone disease and benign prostatic hyperplasia (BPH) and he is a weekly participant in the UH Genitourinary Oncology Tumor Board.
Dr. Jankowski joined the medical staff at University Hospitals in 2018, when he was recruited by urology chairman, Lee Ponsky, MD, to establish a robotic surgery program at UH St. John’s Medical Center, which has grown rapidly under his oversight. He also enjoys participating in the education of urology residents, mentoring them both in the operating room and outpatient clinics. He is also involved in their bi-weekly educational conferences.
After graduating magna cum laude from John Carroll University with a Bachelor of Science in, Dr. Jankowski attended The Ohio State University College of Medicine and Public Health where he earned his medical doctorate. He then completed a general surgery internship and urology residency at Case Western Reserve University, followed by fellowship training in urologic oncology and minimally invasive surgery at City of Hope Cancer Center in Los Angeles. Prior to coming to University Hospitals, he was in private practice in Columbus for ten years where he was well respected by his medical colleagues and elected Chairman of Urology at Riverside Methodist Hospital and the Board of Directors for Central Ohio Urology Group.
Born and raised in Toledo, Ohio Dr. Jankowski lives on the west side of Cleveland with his wife and three daughters. He is an avid golfer and Cleveland/Ohio State sports fan. He also enjoys family runs and coaching his daughters in cross country and track.
Jankowski JT, Cherullo EE, Unni R, Ponsky LE, Metastatic renal cell carcinoma within a previous port site following retroperitoneoscopic radical nephrectomy. Submitted for publication.
Jankowski JT, Sanabria JR. Mini–incision open donor nephrectomy. Submitted for publication.
Jankowski JT, Seftel AD, Strohl KP. Erectile dysfunction and sleep-related disorders. J Urol 2008; 179(3): 837-41.
Jankowski JT, Spirnak JP. Current recommendations for imaging in the management of urologic traumas. Urol Clin North Am 2006; 33(3): 365-76.
Jankowski JT, Palmer JS. Holmium:yttrium-aluminum-garnet laser puncture of ureteroceles in neonatal period. Urology 2006; 68(1):179-81.
Jankowski JT, Spirnak JP. Contemporary detection and management of traumatic posterior urethral injuries. Contemporary Urology 2005; Nov 10-17.
Jankowski JT, Resnick MI, Feng AH. Cystectomy, Partial. eMedicine Journal, 2004; 5(10) – http://www.emedicine.com/med/topic3043.htm.
Lissemore JL, Jankowski JT, Thomas CB, Mascotti DP, and deHaseth PL. Green fluorescent protein as a quantitative reporter of relative promoter activity in E. coli. Biotechniques 2000; 28(1):82-4, 86, 88-9.
“Metastatic Renal Cell Carcinoma Within a Previous Port Site Following Retroperitoneoscopic Radical Nephrectomy” Jankowski JT, Cherullo EE, Unni R, Ponsky LE, World Congress Of Endourology, August 2006
“Niris Optical Coherence Tomography System: Applications in Cystoscopy for Bladder Cancer.” Resnick MI, Kick P, Bodner D, Koch Y, Ponsky, LE , Seftel AD, Jankowski JT, Proano M, MacLennan GT. World Congress of Endourology, August 2006
“Holmium: YAG Laser Incision of Ureteroceles in the Neonatal Period.” Jankowski JT, Palmer JS, Ohio Urological Society Annual Meeting, March 2006
“Synthesis of Sulfur Trioxide – Dioxane Adducts and Characterization by NMR.” Jankowski JT, Brazdil LC, American Chemical Society – Cleveland Sectional Meeting, March 1997
- Urology - American Board of Urology
Fellowship | Urologic Oncology
Urologic Oncology - City Of Hope National Medical Center (2008 - 2009)
Residency | Urology
Urology - Uh Case Medical Center (2004 - 2008)
Residency | General Surgery
General Surgery - Uh Case Medical Center (2002 - 2004)
The Ohio State University College Of Medicine (2002)
John Carroll University (1998)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jason Jankowski did not disclose any Outside Relationships with Industry.